Brief: CHMP Recommends Third Indication For Darolutamide For Patients With Advanced Prostate Cancer
20/06/2025 11:56
June 20 (Reuters) - Orion Oyj ORNBV.HE: CHMP RECOMMENDS THIRD INDICATION FOR DAROLUTAMIDE FOR PATIENTS WITH ADVANCED PROSTATE CANCER ORION - FINAL DECISION ON MARKETING AUTHORISATION FOR DAROLUTAMIDE FROM EUROPEAN COMMISSION ANTICIPATED IN COMING MONTHS Source text: ID:nGNX9zP3x6 Further company coverage: ORNBV.HE ((Reuters.Briefs@thomsonreuters.com;))